Just as a driver’s night vision improves by simply cleaning the headlights, scientists at The University of Texas MD Anderson Cancer Center have discovered that removing an unwanted element from a protein known to suppress the immune system may eventually help clinicians better observe which cancer patients will benefit by treatment with immune checkpoint blockades.
Heng-Huan Lee, Ph.D., a postdoctoral fellow and Ying-Nai Wang,...
MD Anderson researchers will present clinical trial results of promising combination therapies for a variety of cancers at the 2019 American...
Despite a plethora of new and promising treatments available, lung
cancer remains the leading cause of cancer death in the United States,
and will claim more than 150,000 lives this year. November is Lung
Cancer Awareness Month, a time to bring the disease into focus and
educate people about prevention, screening and treatments that save
MD Anderson’s Lung Cancer Moon Shot™ team is committed to making new, patient-guided...